Date: Tuesday, April 12th, 2022

Topic: 340B Drug Pricing Program (22.04)

Recent Legislative Updates and Key Trends Impacting Hospitals, FQHCs, and Other Designated Entities

The CPS 340B Solutions team hosted nationally-recognized 340B industry thought leaders for a roundtable discussion about recent events, legislative updates, and key industry trends that impact all 340B Covered Entity designations. We hope that you enjoy this recording of our session.

During this webinar, speakers discussed topics including:

• Proposed legislation
• Updates regarding bills in the U.S. House and/or Senate
• Contract pharmacies
• Other 340B Program current events

A brief Q&A will occur at the end of the webinar.

- - -

Presenters:

Ted Slafsky
Principal, Wexford Solutions
Publisher and CEO, 340B Report
About: Ted is one of the nation’s leading experts on health care policy, pharmaceutical pricing, the hospital industry, and health care access. Based in Washington, D.C., he is the Founder and Principal of Wexford Solutions LLC where he consults with businesses and non-profits looking to strengthen their position in the marketplace and improve health care outcomes. Mr. Slafsky is also the Publisher and CEO of 340B Report, the only subscription-based news service covering developments in the federal 340B drug pricing program.

Jason Reddish
Partner, Feldesman Tucker Leifer Fidell LLP
About: Jason focuses his practice on the federal 340B drug discount program and the complex legal and compliance issues facing safety net providers, pharmacies, and other 340B program stakeholders. Mr. Reddish began his career representing pharmaceutical manufacturers before finding his passion in helping 340B program covered entities, including disproportionate share hospitals, Federally Qualified Health Centers, Ryan White HIV/AIDS clinics, and other grantees navigate the 340B program.

Kelly Kolker
Executive Vice President, 340B Solutions, CPS

Todd Hudnall
Vice President, 340B Solutions, CPS